Exane Derivatives’s Cronos Group CRON Stock Holding History

Exane Derivatives’s Portfolio CRON Stock Details CRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,751	Closed	-$6.82K	–	832
2022 Q1	$6.82K	Hold	1,751	–	–	﹤0.01%	687
2021 Q4	$6.87K	Hold	1,751	–	–	﹤0.01%	605
2021 Q3	$9.92K	Hold	1,751	–	–	﹤0.01%	708
2021 Q2	$14.2K	Hold	1,751	–	–	﹤0.01%	734
2021 Q1	$16.6K	Sell	1,751 -1,081	-38%	-$11.4K	﹤0.01%	578
2020 Q4	$19.7K	Sell	2,832 -445	-14%	-$3.06K	0.01%	510
2020 Q3	$16.4K	Hold	3,277	–	–	﹤0.01%	451
2020 Q2	$19.7K	Sell	3,277 -5,648	-63%	-$34.5K	0.01%	397
2020 Q1	$50.6K	Sell	8,925 -5,400	-38%	-$35.9K	0.01%	352
2019 Q4	$120K	Sell	14,325 -25,210	-64%	-$193K	0.02%	298
2019 Q3	$358K	Sell	39,535 -5,768	-13%	-$73.7K	0.06%	189
2019 Q2	$724K	Buy	45,303 +18,379	+68%	+$297K	0.13%	132
2019 Q1	$496K	Buy	26,924 +13,724	+104%	+$258K	0.1%	154
2018 Q4	$137K	Buy	13,200 +2,200	+20%	+$21.2K	0.02%	287
2018 Q3	$123K	Buy	+11,000	New	+$93.4K	0.02%	298

Other funds holding CRON

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

IIM

Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return

Merlin Capital Newport, Rhode Island $33.5M AUM 36.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Exane Derivatives's CRON Position: Q2 2022 in Review

Exane Derivatives sold out of Cronos Group (CRON) in Q2 2022, closing a stake of 1,751 shares — an estimated $6.82K sold.

Exane Derivatives first reported a position in CRON in Q3 2018 and held it in 15 quarters. The position peaked at $724K in Q2 2019. 214 funds tracked by Wall St. Rank hold CRON as of Q2 2022.

Exane Derivatives reported no remaining Cronos Group position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 1,751 Cronos Group shares in Q2 2022, an estimated $6.82K.
Exane Derivatives first reported a position in Cronos Group in Q3 2018 and held it in 15 quarters.
Exane Derivatives's Cronos Group position peaked at $724K in Q2 2019.
214 funds tracked by Wall St. Rank held Cronos Group as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.